NEW BRUNSWICK, N.J., Feb. 14, 2018 /PRNewswire-USNewswire/ -- New Jersey Health Foundation (NJHF) has awarded a $50,000Innovation Grant to Alexander Ploss, Ph.D, assistant professor of Molecular Biology at Princeton University, announced James M. Golubieski, president of NJHF.
"If successful, this research could further our understanding of the biology of hepatitis B and E viruses and lead to more advanced treatments for those suffering from these devastating diseases," explained George F. Heinrich, M.D., vice chair and CEO of New Jersey Health Foundation.
Dr. Ploss's research focuses on deciphering the molecular mechanisms of acute and chronic hepatitis virus infections which affect hundreds of millions of people world-wide.
"Infections with hepatitis B virus can be suppressed but remain largely incurable. Hepatitis E virus can result in severe, frequently fatal complications in pregnant women and immunocompromised individuals," he noted.
Through this New Jersey Health Foundation program, Innovation Grants of up to $50,000 each are available to full-time faculty and personnel at major research universities in New Jersey — Kessler Institute, New Jersey Institute of Technology, Princeton University, Rutgers University, Rowan University and Stevens Institute of Technology.
For more information contact Mike Wiley, vice president of Foundation Venture Capital Group, an affiliate of NJHF, at (908) 731-6612 or email@example.com.
About New Jersey Health FoundationNew Jersey Health Foundation is a not-for-profit corporation that supports health-related research and education programs in New Jersey through its Grants Program and its affiliate, Foundation Venture Capital Group which makes private equity investments in health-related start- up companies in New Jersey headed toward commercialization.
View original content:http://www.prnewswire.com/news-releases/new-jersey-health-foundation-awards-50000-innovation-grant-to-princeton-university-researcher-advancing-hepatitis-treatments-300598724.html
SOURCE New Jersey Health Foundation
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All